Flunixin (Resflor, Finadyne, Banamine)
Flunixin
Intervet South Africa (Pty) Ltd
Registration
- Applicant
- Intervet South Africa (Pty) Ltd
- Registrations
- 4
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Resflor EACH 1,0 ml SOLUTION CONTAINS FLORFENICOL A 300,0 mg FLUNIXIN MEGLUMINE A EQUIVALENT TO FLUNIXIN 16,5 mg | Not listed | 17-Jun06/21.1/17 | Registered | Not determined | None |
| Finadyne injection EACH 1 ml CONTAINS FLUNIXIN MEGLUMINE EQUIVALENT TO FLUNIXIN 50 mg | Injection | 83/6383/2.6/63 | Registered | Not determined | None |
| Banamine EACH 1,0 ml SOLUTION CONTAINS FLUNIXIN MEGLUMINE EQUIVALENT TO FLUNIXIN 50,0 mg | Not listed | 9-Jan01/2.6/9 | Registered | Not determined | None |
| Finadyne 20 MG EACH TABLET CONTAINS FLUNIXIN MEGLUMINE EQUIVALENT TO FLUNIXIN 20 mg | 20 mg | 91/391/2.6/3 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Florfenicol
Consolidated Schedules 06 July 2026, line 6345
S3: Flunixin
Consolidated Schedules 06 July 2026, line 3606
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
2-[2-Methyl-3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid
Drag to rotate. Structure from PubChem CID 38081.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.